Colorectal Cancer Market is Estimated to Grow at a CAGR over 1.8% by 2022

Apr 24, 2017

Middle-East and Africa Colorectal Cancer Market Analysis by Type (Adenocarcinomas), Diagnosis (Faecal Occult Blood Test) and Treatment Type - Forecast to 2022

Pune, India - April 24, 2017 /MarketersMedia/ —

Market Overview:

Middle-East and Africa Colorectal Cancer Market has been evaluated as steadily growing market and it is expected that the market will continue to grow at same pace in the near future. Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers can also know as colon cancer or rectal cancer, depending on where they start. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, Diarrhea, Pains in the abdomen, Vomiting, and feeling tired all the time.

Globally, around 1.4 million people diagnosed in 2014, in Middle-East and Africa approximately 5000 are suffering from Colorectal Cancer throughout Middle-East and Africa. About 80% of orphan disorders are genetic origin. Rising consumer awareness and continuous development of treatment for Colorectal Cancer are driving the growth for the Middle-East and Africa colorectal cancer market. Major drugs manufacturers are investing amount of money for R & D to find cure for colorectal cancer. Increasing funding and overall increased expenditure for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Colorectal Cancer. Middle-East and Africa Colorectal Cancer Market was estimated around US$ 0.8 billion in 2015 and is expected to reach US$ 0.90 billion by 2022 at a CAGR of 1.8%. There are several factors which are prohibiting the growth of the market such as extremely high cost of cancer treatment and drugs, lack of early diagnosis, lack of awareness and healthcare facilities particularly in African countries etc.

Market Players:

F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany)

Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/2551

Regional Analysis:

Considering the Middle-East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Colorectal Cancer. Moreover Saudi Arabia market is also growing and second largest market for Patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 80 numbers of pages of the project report “Middle-East and Africa Colorectal Cancer Market- Forecast to 2022”

Market Segmentation:

Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/mea-colorectal-cancer-market-2551

Intended Audience

• Middle-East and Africa Colorectal Cancer Equipment manufacturers
• Middle-East and Africa Colorectal Cancer Equipment Suppliers
• Government and Independent Regulatory Authorities
• Research and Development (R&D) Companies
• Independent Research Laboratories
• Market Research and Consulting Service Providers
• Medical Research Laboratories

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Akash Anand
Email: [email protected]
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/colorectal-cancer-market-is-estimated-to-grow-at-a-cagr-over-1-8-by-2022/189547

For more information, please visit https://www.marketresearchfuture.com

Source: MarketersMedia

Release ID: 189547

More News

PascualLab marks 80 years with free checkups and health donations

Nov 10, 2026

PascualLab marks 80 years with free checkups and health donations

Ninety members of Asilo de San Vicente de Paul in Manila received free medical checkups and cough remedies in October through a partnership between Pascual Laboratories Inc. (PascualLab) and Caritas Manila. The outreach marked the pharmaceutical company’s 80th anniversary and also served as the occasion for the two organizations to sign a memorandum of agreement. PascualLab employees volunteered at the event. Through Caritas Manila’s community network and logistical support, the company plans to extend the outreach to more people in need. Products earmarked for distribution include Poten-Cee vitamin C for adults and children, lagundi leaf preparations, C-Lium Fibre food supplements and OraCare mouthrinse. The partnership is part of PascualLab’s corporate social responsibility program, Sowing to Empower, Educate and Develop (SEED). Caritas Manila, the Catholic Church’s social welfare arm, works with communities such as Asilo de San Vicente de Paul. PascualLab said the collaboration supports two United Nations Sustainable Development Goals, one focused on good health and well-being and the other on partnerships to achieve the goals. Leonora and Isosceles Pascual founded the company in 1946 to help meet demand for Vitamin C and provide tuberculosis relief in the postwar years. Over the next eight decades, the company expanded its product line to include food supplements, cough remedies and oral care products. As part of the anniversary, PascualLab also donated Ascof Lagundi Ponkan to children in need on behalf of members of the media.

The emotional toll of living with psoriasis

Nov 10, 2026

The emotional toll of living with psoriasis

For more than two decades, Sheryll Cledera has lived with psoriasis, a chronic skin condition that changed how she looked, how she felt and how she interacted with others. The 50-year-old mother from Pasig City began researching and self-medicating in 2001. Over the years, she sought treatment from different clinics, experiencing periods of hope and discouragement as she struggled to manage the condition. Her story was featured in Saturday’s episode of “Kutis Reveal,” where host Dr. Kei Rebolledo and the Kutis by Kei Clinic team helped her work toward healthier skin and renewed confidence. During her consultation, Cledera recalled feeling judged by strangers through their stares, an experience that affected her mental health and social interactions. She also shared how psoriasis contributed to depression and difficulty sleeping. Dr. Rebolledo explained the condition and addressed common misconceptions, particularly the belief that psoriasis is contagious. He discussed available treatment options, evidence-based solutions and what the clinic’s technology could realistically achieve. The consultation also focused on Cledera’s expectations and personal struggles. Dr. Rebolledo listened to her experiences and offered guidance tailored to her needs. The journey addressed both her medical treatment and emotional well-being. Under the care of Dr. Rebolledo’s team, Cledera underwent procedures to improve her skin condition, along with additional aesthetic treatments to enhance her overall appearance. Her transformation was especially meaningful to her family, including her daughter, who had witnessed her mother’s struggles through the years. “Bumalik ang shine niya and makitaan siya ng will to be her confident self again (She got her sparkle back, and I could see she wanted to feel like her confident self again),” her daughter said. Last Saturday’s episode showed how medical expertise, personalized treatment and family support can help patients rebuild their confidence and reconnect with their social lives. Hosted by celebrity dermatologist Dr. Kei Rebolledo, “Kutis Reveal” airs every Saturday at 10 a.m. on Bilyonaryo News Channel (Channel 31).

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.